Oncology Pharma Inc. (ONPH)
Oncology Pharma Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in San Francisco, CA, US. The stock last traded at $0.05, down 24.64% on the session, giving a market capitalisation of $1.4M. On trailing twelve-month figures it carries a trailing P/E of 520.00, a net margin of 0.0%. Its beta of -0.13 implies it has historically moved less than the broad market.
Oncology Pharma Inc. is a pharmaceutical firm specializing in oncology, dedicated to the development, manufacturing, and commercialization of therapeutic agents. The company has a collaborative and licensing agreement with Kalos Therapeutics Inc. to explore treatment possibilities for the COVID-19 virus. Originally incorporated in 1993, the company was known as SourcingLink.net Inc. until it rebranded as Oncology Pharma Inc. in June 2019. Its operations are based in San Francisco, California.
Oncology Pharma Inc. is most often compared with the following Healthcare names: